Liver metastasis

Last updated
Metastatic liver disease
MultipleLiverMets2008.jpg
Axial CT of the abdomen showing multiple liver metastases
Specialty Hepatology, oncology

A liver metastasis is a malignant tumor in the liver that has spread from another organ that is affected by cancer. This can also be called secondary liver cancer or metastatic liver disease. The liver is a common site for metastatic disease because of its rich, dual blood supply (the liver receives blood via the hepatic artery and portal vein). Metastatic tumors in the liver are 20 times more common than primary liver tumors (tumors that originate in the liver). In 50% of all cases the primary tumor is of the gastrointestinal tract; other common sites include the breast, ovaries, bronchus and kidney. People with colorectal cancer are at risk of liver metastases. [1]

Contents

Signs and symptoms

The signs and symptoms of secondary liver cancer are usually fairly non-specific (they can also be caused by other things). The following is a list of possible signs and symptoms of liver metastasis: [2]

Clinical signs include:

Causes

Liver metastasis is common in people with metastatic cancer. The rich blood supply in the liver, the role of filtering the blood from the digestive organs lead to the liver, and diverse cell types make the liver a common place for cancer metastasis. [3] [4] Metastases to the liver are more frequently diagnosed in people than primary liver cancers such as hepatocellular carcinoma or cholangiocarcinoma. [3] Most hepatic metastases originate from adenocarcinomas, though other less common types such as squamous cell carcinoma, neuroendocrine tumors, lymphoma, sarcoma, and melanoma are also found. [3]

Mechanism

Different cell types in the liver are involved in promoting and then sustaining the cancer metastasis in the liver. Cell types include: Kupffer cells, parenchymal hepatocytes, sinusoidal endothelial cells in the liver, dendritic cells, and blood based immune cells (monocytes, macrophages, neutrophils). [5] The metastasis develops in four phases:1) microvascular development, 2) pre-angiogenic phase, 3) angiogenic phase (growth of blood vessels), and 4), growth of the tumor phase. [5]

Tumor emboli entering the sinusoids through the liver blood supply appear to be physically obstructed by the Kupffer cells, but if tumor emboli are larger, they tend to become lodged in the portal venous branches.[ citation needed ]

Diagnosis

Imaging such as triple-phase CT scans or MRI's are required to evaluate and diagnose a suspected metastasis on the liver. [5] The imaging may also provide information about the source of the primary disease. [3] Other diagnostic criteria include:[ medical citation needed ]

Treatment

The first line of treatment is surgical resection of the affected tissue(hepatectomy). [3] Other treatments include chemotherapy and/or therapies specifically aimed at the liver like radiofrequency ablation, transcatheter arterial chemoembolization, selective internal radiation therapy and irreversible electroporation.[ medical citation needed ] For most patients no effective treatment exists because both lobes are usually involved, making surgical resection impossible. Younger patients with metastases from colorectal cancer confined to one lobe of the liver and up to 4 in number may be treated by partial hepatectomy. In selected cases, chemotherapy may be given systemically or via hepatic artery.[ medical citation needed ]

In some tumors, notably those arising from the colon and rectum, apparently solitary metastases or metastases to one or other lobes may be resected. A careful search for other metastases is required, including local recurrence of the original primary tumor (e.g., via colonoscopy) and dissemination elsewhere (e.g., via CT of the thorax). 5-year survival rates of 30-40% have been reported following resection. [ citation needed ]

When resection for cure is not possible (R0 resection), percutaneous ethanol injection has been suggested to dehydrate and kill the tumour cells, however there is not enough evidence to determine the effectiveness and safety of this approach. [7]

Newer therapeutic approaches include full body (systemic) therapies, bevacizumab, cetuximab, and immunomodulator medications. [5]

Epidemiology

Over 5% of people with primary cancer developed liver metastasis. [4] In 70% to 80% of metastatic colorectal cancer cases, the spread is limited to the liver. [3] The overall survival at 1-year has been estimated to be about 15%. [4] Overall, survival may be lower in people with primary cancer in the testis, breast, prostate, anus, and people with melanoma. [4]

References

  1. Yunshi., Qin, Xinyu. Xu, Jianmin. Zhong (2017). Multidisciplinary Management of Liver Metastases in Colorectal Cancer : Early Diagnosis and Treatment. Springer Netherlands. ISBN   978-94-017-7755-1. OCLC   981559278.{{cite book}}: CS1 maint: multiple names: authors list (link)
  2. "What is secondary liver cancer?". www.cancerresearchuk.org. Retrieved 2025-05-02.
  3. 1 2 3 4 5 6 Griscom, James T.; Wolf, Patrick S. (2025), "Liver Metastasis", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   31971757 , retrieved 2025-05-02
  4. 1 2 3 4 Horn, Samantha R; Stoltzfus, Kelsey C; Lehrer, Eric J; Dawson, Laura A.; Tchelebi, Leila; Gusani, Niraj J; Sharma, Navesh K; Chen, Hanbo; Trifiletti, Daniel M; Zaorsky, Nicholas G (2020-08-01). "Epidemiology of liver metastases" . Cancer Epidemiology. 67: 101760. doi:10.1016/j.canep.2020.101760. ISSN   1877-7821.
  5. 1 2 3 4 Tsilimigras, Diamantis I.; Brodt, Pnina; Clavien, Pierre-Alain; Muschel, Ruth J.; D’Angelica, Michael I.; Endo, Itaru; Parks, Rowan W.; Doyle, Majella; de Santibañes, Eduardo; Pawlik, Timothy M. (2021-04-15). "Liver metastases" . Nature Reviews Disease Primers. 7 (1): 1–23. doi:10.1038/s41572-021-00261-6. hdl: 20.500.11820/0160d163-d126-4ae1-ac6c-a7b098a95468 . ISSN   2056-676X.
  6. List of included entries and references is found on main image page in Commons: Commons:File:Metastasis sites for common cancers.svg#Summary
  7. Swierz, Mateusz J.; Storman, Dawid; Riemsma, Robert P.; Wolff, Robert; Mitus, Jerzy W.; Pedziwiatr, Michal; Kleijnen, Jos; Bala, Malgorzata M. (April 2020). "Percutaneous ethanol injection for liver metastases". The Cochrane Database of Systematic Reviews. 2020 (2): CD008717. doi:10.1002/14651858.CD008717.pub3. ISSN   1469-493X. PMC   7000212 . PMID   32017845.